Plain-English translation of NCT00695214 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial evaluates a procedure called drug-induced sleep endoscopy (DISE), which uses a small camera to examine your upper airway while you're under mild sedation with propofol. The study aims to see how well this procedure helps doctors understand where your airway is collapsing during sleep and how it can guide surgical treatment decisions for obstructive sleep apnea.
Sleep apnea surgery doesn't work for everyone, and doctors need better tools to understand exactly where and why your airway is closing. This medication and procedure combination may help doctors see the airway more clearly and choose the best surgical approach for each patient.
You likely qualify if…
You likely don't qualify if…
You would undergo the drug-induced sleep endoscopy procedure, where doctors give you mild sedation to help you relax and then use a small camera to examine your upper airway. The procedure allows doctors to see exactly where your airway is collapsing and helps them plan the best surgical approach for you. Researchers will also compare these findings to other imaging tests and track how well any surgery works for you.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
United States
Testing effectiveness
Sponsor
University of California, Los Angeles
Collaborators
National Institutes of Health (NIH), American Academy of Otolaryngology-Head and Neck Surgery Foundation
Enrollment target
~800 participants
Started
February 2004
Primary completion
June 2035
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Eric J Kezirian, MD, MPH
University of California, Los Angeles
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.